BamSEC and AlphaSense Join Forces
Learn More

Bio Green Med Solution, Inc. – Underwriting Agreements

NASDAQ: BGMS    
Share price (7/15/26): $0.91    
Market cap (7/15/26): $4.997 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1
from SCHEDULE 13G/A 13 pages Amended and Restated Series a Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-1
from SCHEDULE 13G/A 13 pages Amended and Restated Series a Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-1
from SCHEDULE 13G/A 13 pages Amended and Restated Series a Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-1
from SCHEDULE 13D/A 1 page Transactions in the Securities of the Issuer During the Past Sixty Days Shares of Common Stock Sold Price Per Share Date of Sale 15,011 $9.65 8/4/2025 114,618 $9.31 8/5/2025
12/34/56
EX-1
from SCHEDULE 13D/A 1 page Transactions in the Securities of the Issuer During the Past Sixty Days Shares of Common Stock Sold Price Per Share Date of Sale 6,750 $12.36 7/30/2025 15,000 $11.68 7/31/2025 10.22 $10.22 8/1/2025
12/34/56
EX-1.1
from S-1/A 18 pages Placement Agency Agreement
12/34/56
EX-1
from SC 13G/A 1 page Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.1
from 10-Q 46 pages ​ ​ Cyclacel Pharmaceuticals, Inc. Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-1.1
from 8-K 36 pages 1,807,143 Shares of Common Stock of Cyclacel Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13G 1 page Joint Filing Statement Statement Pursuant to Rule 13d-1
12/34/56
EX-1.2
from 8-K 36 pages Securities Purchase Agreement
12/34/56
EX-1.1
from 8-K 16 pages Co-Placement Agency Agreement
12/34/56
EX-1.1
from S-1/A 15 pages Co-Placement Agency Agreement
12/34/56
EX-1.1
from 8-K 33 pages Cyclacel Pharmaceuticals, Inc. Common Stock Sales Agreement
12/34/56
EX-1
from SC 13D 1 page Cusip No. 23254l405 Exhibit 1 Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 42 pages 2,164,000 Shares of Common Stock, 8,872 Shares of Series a Convertible Preferred Stock (Convertible Into 4,436,000 Shares of Common Stock) and 6,600,000 Warrants (Exercisable for 6,600,000 Shares of Common Stock) of Cyclacel Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 41 pages Shares of Common Stock, Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock) and Warrants (Exercisable for Shares of Common Stock) of Cyclacel Pharmaceuticals, Inc. Form of Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 41 pages Shares of Common Stock, Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock) and Warrants (Exercisable for Shares of Common Stock) of Cyclacel Pharmaceuticals, Inc. Form of Underwriting Agreement
12/34/56
EX-1.1
from 8-K 45 pages Cyclacel Pharmaceuticals, Inc. Shares of Common Stock (Par Value $0.001 Per Share) at Market Issuance Sales Agreement
12/34/56